Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M338Revenue (TTM) $M5.5Net Margin (%)-2,383.2Altman Z-Score2.5
Enterprise Value $M122EPS (TTM) $-1.3Operating Margin %-2,430.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.5Pre-tax Margin (%)-2,383.2Higher ROA y-yY
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio11.4Cash flow > EarningsY
Price/Sales61.15-y EBITDA Growth Rate %--Current Ratio11.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-45.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M101ROIC % (ttm)-1,206.3Gross Margin Increase y-yN

Gurus Latest Trades with CLDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CLDXFirst Eagle Investment 2016-06-30 Reduce$3.46 - $5
($4.23)
$ 3.50-17%Reduce -29.31%445,000
CLDXJohn Paulson 2016-03-31 Buy $3.17 - $15.68
($7.68)
$ 3.50-54%New holding70,800
CLDXFirst Eagle Investment 2016-03-31 Add$3.17 - $15.68
($7.68)
$ 3.50-54%Add 8.63%629,542
CLDXFirst Eagle Investment 2015-12-31 Add$11.45 - $18.11
($14.68)
$ 3.50-76%Add 3.57%579,542
CLDXJoel Greenblatt 2015-06-30 Sold Out -0.01%$23.67 - $30.1
($26.5)
$ 3.50-87%Sold Out0
CLDXJoel Greenblatt 2015-03-31 Buy 0.01%$18.29 - $31.78
($23.85)
$ 3.50-85%New holding35,223
CLDXFirst Eagle Investment 2014-12-31 Add0.01%$12.55 - $20.93
($16.61)
$ 3.50-79%Add 123.82%559,542
CLDXFirst Eagle Investment 2014-09-30 Buy 0.01%$12.05 - $17.57
($14.51)
$ 3.50-76%New holding250,000
CLDXFirst Eagle Investment 2014-03-31 Sold Out -0.0089%$16.95 - $31.59
($25.58)
$ 3.50-86%Sold Out0
CLDXFirst Eagle Investment 2013-12-31 Reduce-0.04%$21.51 - $36.71
($25.51)
$ 3.50-86%Reduce -75.45%135,000
CLDXFirst Eagle Investment 2013-06-30 Reduce-0.02%$11.01 - $16.09
($13.13)
$ 3.50-73%Reduce -45.89%665,560
CLDXGeorge Soros 2012-06-30 Sold Out -0.06%$3.9 - $5.26
($4.39)
$ 3.50-20%Sold Out0
CLDXFirst Eagle Investment 2012-06-30 Add0.02%$3.9 - $5.26
($4.39)
$ 3.50-20%Add 260.87%1,660,000
CLDXGeorge Soros 2012-03-31 Buy 0.06%$2.77 - $5.46
($4)
$ 3.50-13%New holding803,200
CLDXFirst Eagle Investment 2012-03-31 Add0.01%$2.77 - $5.46
($4)
$ 3.50-13%Add 360.00%460,000
CLDXFirst Eagle Investment 2011-12-31 Reduce$2.11 - $3.21
($2.7)
$ 3.5030%Reduce -71.43%100,000
CLDXFirst Eagle Investment 2011-06-30 Buy 0.01%$3.03 - $4.46
($3.75)
$ 3.50-7%New holding350,000
CLDXFirst Eagle Investment 2010-03-31 Sold Out $4.35 - $6.39
($4.94)
$ 3.50-29%Sold Out0
CLDXFirst Eagle Investment 2009-12-31 Buy $4.2 - $5.66
($4.78)
$ 3.50-27%New holding100,000
CLDXFirst Eagle Investment 2009-09-30 Sold Out $4.95 - $7.93
($6.33)
$ 3.50-45%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CLDX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CLDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CATLIN AVERY WSr. VP & CFO 2015-11-23Sell25,000$18-80.56view
ELLBERGER LARRYDirector 2015-08-25Buy5,000$14-75view
ELLBERGER LARRYDirector 2015-08-20Buy5,000$15-76.67view
ELLBERGER LARRYDirector 2015-08-18Buy5,000$15.95-78.06view
ELLBERGER LARRYDirector 2015-08-13Buy5,000$16.59-78.9view
Marucci Anthony SPresident and CEO 2015-08-13Buy5,800$16.81-79.18view
CATLIN AVERY WSr. VP & CFO 2015-06-15Sell25,000$24.59-85.77view
van den Broek RichardDirector 2014-12-17Sell0$0-85.77view
LIPTON KAREN SHOOSDirector 2013-12-06Sell17,728$24.5-85.71view
PENNER HARRY JRDirector 2013-12-06Sell17,728$24.5-85.71view

Quarterly/Annual Reports about CLDX:

News about cldx:

Articles On GuruFocus.com
Cantor Fitzgerald and Brean Capital Positive on Celldex Therapeutics Following Positive Data For Bra Jun 01 2015 
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
Cowen & Co Remains Bullish on Celldex Therapeutics Following FDA 'Breakthrough' Approval Feb 24 2015 
CLDX up 223%, Cohen Gains Big Apr 23 2013 
Steve Cohen Increases Celldex Up 145% Apr 06 2013 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
CELLDEX THERAPEUTICS, INC (CLDX) CEO Anthony S Marucci buys 12,000 Shares Sep 13 2010 
Weekly CFO Buys Highlight: GNMK, RTIX, BKOR, PTEK, CLDX Sep 12 2010 
CELLDEX THERAPEUTICS, INC Reports Operating Results (10-Q) Aug 05 2010 

More From Other Websites
ETF’s with exposure to Celldex Therapeutics, Inc. : August 18, 2016 Aug 18 2016
Biotech Industry on the Upswing after Rocky Start to 2016 Aug 17 2016
CELLDEX THERAPEUTICS, INC. Financials Aug 16 2016
Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 Aug 16 2016
Celldex Appoints Elizabeth Crowley as Chief Product Development Officer Aug 11 2016
CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Aug 11 2016
Celldex Appoints Elizabeth Crowley as Chief Product Development Officer Aug 11 2016
Celldex Therapeutics (CLDX) Stock Up on Q2 Results Aug 09 2016
Celldex (CLDX) Posts Narrower Q2 Loss, Focus on Pipeline Aug 09 2016
Celldex reports 2Q loss Aug 08 2016
Celldex reports 2Q loss Aug 08 2016
Celldex reports 2Q loss Aug 08 2016
Celldex Therapeutics Inc Earnings Call scheduled for 4:30 pm ET today Aug 08 2016
Celldex Reports Second Quarter 2016 Results Aug 08 2016
CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 08 2016
Celldex Reports Second Quarter 2016 Results Aug 08 2016
ETF’s with exposure to Celldex Therapeutics, Inc. : August 8, 2016 Aug 08 2016
Q2 2016 Celldex Therapeutics Inc Earnings Release - After Market Close Aug 08 2016
Celldex Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CLDX-US : August... Aug 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)